EUVIMEDEuropean Health Evidence
Uhr 10/10Sources Journal Tree
Easy Demo

Lokaler Crossref-Datenbestand · journal-article

Direct comparison of serine restriction on the viability of normal and cancer cells demonstrates that methionine restriction is more cancer specific

Yuta Miyashi, Tomoyuki Ishiguro, Qinghong Han, Shukuan Li, Byung Mo Kang, Michael Bouvet, Yasunori Tome, Kotaro Nishida, Robert M. Hoffman

Frontiers in Oncology · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Background/aim Many studies in the present century have stated that restriction of serine is a cancer-specific vulnerability. The present study aimed to determine whether restriction of serine, compared to restriction of methionine, distinguishes cancer and normal cells. Materials and methods 143B-RFP osteosarcoma cells, HT1080-RFP fibrosarcoma cells, HCT116-GFP colon-cancer cells, and Hs27 normal fibroblasts were used in the present study. All cells are of human origin. Cancer and normal cells were cultured in RPMI-1640 medium without serine and glycine for serine/glycine restriction, and in Dulbecco’s modified Eagle’s medium without methionine for methionine restriction, each supplemented with 10% dialyzed fetal bovine serum. Cancer and normal cells were cultured in 96-well plates at 2 × 10 3 cells/well. Serine, glycine, and methionine were added back as controls. Cell viability was measured with the WST-8 cell-viability reagent to establish dose-response curves for serine (with or without glycine) and for methionine in cancer and normal cells. Each cancer cell line was also co-cultured with Hs27 normal fibroblasts in 12-well plates. Each cell type was evaluated by phase-contrast and GFP/RFP fluorescence microscopy to determine the effects of serine/glycine restriction or methionine restriction. Results Serine restriction alone did not distinguish cancer and normal cells. Both 143B osteosarcoma and Hs27 normal fibroblasts maintained approximately 100% viability without serine in glycine-containing medium. The HT1080-RFP and HCT116-GFP cancer cells lost approximately 40% of their viability without serine and showed increasing viability with increasing serine concentration. When both serine and glycine were restricted, Hs27 fibroblasts lost approximately 20% viability, whereas all cancer cells lost about 40% viability. Neither serine restriction nor serine/glycine restriction could lower the viability of cancer cells to 50% of control. In co-culture, the removal of serine and glycine still left many cancer cells viable. In contrast, methionine removal caused a much greater reduction in cancer-cell viability than removal of serine/glycine. Hs27 normal fibroblasts survived well under both serine/glycine and methionine restriction. Conclusion Serine restriction and serine/glycine restriction are not as cancer-specific as methionine restriction.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Yuta Miyashi, Tomoyuki Ishiguro, Qinghong Han, Shukuan Li, Byung Mo Kang, Michael Bouvet, Yasunori Tome, Kotaro Nishida, Robert M. Hoffman
Quelle
Frontiers in Oncology
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
2234-943X
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Yuta Miyashi, Tomoyuki Ishiguro, Qinghong Han, Shukuan Li, Byung Mo Kang, Michael Bouvet, Yasunori Tome, Kotaro Nishida, Robert M. Hoffman (2026). Direct comparison of serine restriction on the viability of normal and cancer cells demonstrates that methionine restriction is more cancer specific. Frontiers in Oncology. https://doi.org/10.3389/fonc.2026.1931323
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1